As part of our coverage of the ASH Annual Meeting, we are discussing novel agents and strategies for relapsed/refractory Hodgkin lymphoma.
Craig H. Moskowitz, MD
Advertisement
Articles by Craig H. Moskowitz, MD
Advertisement
Latest Updated Articles
Getting to Transplant Remains Goal in Relapsed/Refractory Hodgkin LymphomaPublished: December 2nd 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
3
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
4
Taking Stock of Immune Effector Cell Therapy Developments in GI Cancers
5
